AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO)

Core Viewpoint - The analysis indicates a positive outlook on AngioDynamics, Inc. (NASDAQ: ANGO) due to its expanding portfolio in medical technology, suggesting potential investment opportunities in the company [1]. Company Summary - AngioDynamics is recognized for its growth in the medical technology sector, which is often overlooked by many investors, particularly in the small- to mid-cap range [1]. - The company has been rated a Buy, reflecting confidence in its future performance and market position [1]. Industry Context - The analysis occasionally includes insights on large-cap companies to provide a broader perspective on equity markets, indicating that AngioDynamics operates within a competitive landscape that includes both small and large players [1].